Early diagnosis of psoriatic arthritis will prevent joint damage and improve long-term patient outcome. For dermatologists and general practitioners, early recognition of the diverse musculoskeletal manifestations can prove problematic. Screening tools and biomarkers offer great promise—the recent description and initial validation of the EARP tool is an encouraging development.
